The utrophin-beta 2 syntrophin complex regulates adipocyte lipid droplet size independent of adipogenesis

Molecular and Cellular Biochemistry
Sabrina KrautbauerChrista Buechler

Abstract

Utrophin is a widely expressed cytoskeleton protein and is associated with lipid droplets (LDs) in adipocytes. The scaffold protein beta 2 syntrophin (SNTB2) controls signaling events by recruiting distinct membrane and cytoskeletal proteins, and binds to utrophin. Here we show that SNTB2 forms a complex with utrophin in adipocytes. SNTB2 protein is strongly diminished when utrophin is low. Of note, knock-down of utrophin or SNTB2 enhances LD growth during adipogenesis. SNTB2 reduction has no effect on basal and induced lipolysis, and insulin-stimulated phosphorylation of Akt is normal. The antilipolytic activity of insulin is enhanced in adipocytes with low SNTB2, while knock-down of utrophin has no effect. Uptake of exogenously supplied oleate and linoleate is comparable in scrambled and SNTB2 siRNA-treated cells. In the fibroblasts, diminished SNTB2 is associated with lower proliferation. CCAAT/enhancer-binding protein alpha and sterol regulatory element-binding proteins which are critical transcription factors for adipogenesis are normally expressed. Consequently, maturation of cells with SNTB2 knock-down is not grossly impaired. In fibroblasts, SNTB2 is localized to filamentous and vesicular structures which are distinct f...Continue Reading

References

Jun 11, 2002·Biochemical and Biophysical Research Communications·Christa BuechlerGerd Schmitz
Jul 30, 2005·Arteriosclerosis, Thrombosis, and Vascular Biology·Pontus BoströmSven-Olof Olofsson
Oct 3, 2006·Cell Metabolism·Stephen R Farmer
Jan 19, 2008·Endocrinology·Nicole A Ducharme, Perry E Bickel
Mar 13, 2008·The Journal of Biological Chemistry·Pernille KellerOrmond A MacDougald
Mar 28, 2009·PLoS Computational Biology·Junghyo JoVipul Periwal
Dec 15, 2010·Biochemical and Biophysical Research Communications·José Romo-YáñezLuis A Salazar-Olivo
Jun 3, 2011·The Journal of Clinical Investigation·Andrew S GreenbergDouglas G Mashek
Aug 19, 2011·Biochemical and Biophysical Research Communications·John S LyssandChris Hague
Mar 30, 2012·Molecular Biology of the Cell·Nicholas AriottiRobert G Parton
Apr 21, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Li XuPeng Li
May 23, 2012·Vascular Pharmacology·Cristiano Capurso, Antonio Capurso
Dec 25, 2012·Cellular and Molecular Life Sciences : CMLS·Hina F BhatFirdous A Khanday
Jul 19, 2013·Experimental and Molecular Pathology·Markus NeumeierChrista Buechler
Aug 21, 2013·Cell Metabolism·Kai SunPhilipp E Scherer
Mar 15, 2014·Nature Reviews. Drug Discovery·Alan S VerkmanMarios C Papadopoulos
Apr 18, 2014·Molecular and Cellular Biochemistry·Sabrina KrautbauerChrista Buechler
May 30, 2014·Nutrition Research Reviews·Gema FrühbeckAmaia Rodríguez
Jun 5, 2014·Journal of Genetics and Genomics = Yi Chuan Xue Bao·Jolene S Y TanDavid L Silver
Jan 28, 2015·Biochimica Et Biophysica Acta·Tobias HebelChrista Buechler
Apr 29, 2015·Acta Biochimica Et Biophysica Sinica·Dan OuyangYugu Li
May 20, 2015·World Journal of Diabetes·Christa BuechlerKristina Eisinger
Jul 1, 2015·Experimental Cell Research·Federico BoschiAndrea Sbarbati
Mar 8, 2016·Journal of Lipid Research·Yanfei QiHongyuan Yang
Jun 1, 2016·Experimental Cell Research·Kristina EisingerChrista Buechler
Apr 28, 2018·Experimental and Molecular Pathology·Kristina EisingerChrista Buechler

❮ Previous
Next ❯

Citations

Jan 8, 2020·Contact·Marcus D Kilwein, M A Welte

❮ Previous
Next ❯

Methods Mentioned

BETA
Assay
transfection
electrophoresis
immunoprecipitation

Software Mentioned

SPSS Statistics
MS Excel

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.